HAVN Life To Begin Supplying its Naturally Derived Psilocybin Products For Use in World’s Largest Medical Psilocybin and… Jul 28, 2022
Awakn Life Sciences’ Phase III Trial Approved for Approximately CA$2.5 Million Funding from UK State Covering 66%… Jul 20, 2022
Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs Jul 19, 2022
